**To the Editor:** Plasmid-mediated, colistin-resistance mechanism gene *mcr-1* was first identified in *Escherichia coli* isolates from food, food animals, and human patients in November 2015 ([@R1]). Reports on detection of *mcr-1* in *Enterobacteriaceae* from humans and food animals soon followed from ≈12 countries ([@R2]--[@R5]). Here we report detection of *mcr-1* in colistin-resistant *E. coli* isolated from companion animals and the possible transmission of *mcr-1*--harboring *E. coli* between companion animals and a person.

Three *mcr-1*--harboring *E. coli* clinical isolates were identified from specimens of 3 patients admitted to a urology ward of a hospital in Guangzhou, China. *E. coli* isolate EC07 was identified in the urine of a 50-year-old male patient with glomerulonephritis in October 2015. Isolate EC08 was cultured from the urine of a 48-year-old male patient with prostatitis in December 2015. IsolateEC09 was identified in the blood of an 80-year-old male patient with bladder cancer 3 weeks after EC08 was identified.

Review of medical records identified the patient carrying *E. coli* isolate EC07 as a worker at a pet shop. In light of this finding, we collected a total of 53 fecal samples from 39 dogs and 14 cats in the pet shop where the man worked. We isolated and identified colonies consistent with *E. coli* from fecal samples on MacConkey agar plates (Thermo Fisher, Beijing, China) and API 20E system (bioMérieux, Durham, NC, USA). We prepared crude DNA samples of isolates for PCR testing by boiling cells in water. Among them, 6 were positive for *mcr-1* by PCR and sequencing (4 from dogs and 2 from cats). All 6 isolates were resistant to colistin, polymyxin B, cephalosporin, gentamicin, and ciprofloxacin by using the agar dilution method, in accordance with the European Committee on Antimicrobial Susceptibility Testing (<http://www.eucast.org>) for colistin and polymyxin B and Clinical and Laboratory Standards Institute guidelines (<http://www.clsi.org>) for the other antimicrobial drugs. We identified various resistance genes accounting for the multidrug resistance in these 9 *mcr-1--*positive isolates ([@R6],[@R7]) ([Table](#T1){ref-type="table"}). We noted that *E. coli* isolate EC09 was also resistant to carbapenems and positive for *bla*~IMP-4~. We observed co-production of *mcr-1* and IMP-type metallo-β-lactamase in *E. coli*.

###### Characteristics of 9 *mcr-1*--positive *Escherichia coli* isolates from companion animals and human patients, Guangzhou, China

  Characteristic       Isolate                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
  -------------------- ------------------------------- ---------------------------------------------------------------- ---------------------------------------------------------------- ---------------------------------------------------------------- ------------------------------------------------------------------------------------------- ---------------------------------------------------------------- ---------------------------------------------------------------- -------------------------------------------------------------- ----------------------------------------------------------------------------
  Isolation date       2016 Jan 1                      2016 Jan 1                                                       2016 Jan 2                                                       2016 Jan 2                                                       2016 Jan 2                                                                                  2016 Jan 4                                                       2015 Oct 10                                                      2015 Nov 2                                                     2015 Nov 21
  Specimen source      Cat                             Dog                                                              Dog                                                              Dog                                                              Cat                                                                                         Dog                                                              Human                                                            Human                                                          Human
  Specimen type        Feces                           Feces                                                            Feces                                                            Feces                                                            Feces                                                                                       Feces                                                            Urine                                                            Urine                                                          Blood
  Phylogenetic group   B2                              D                                                                D                                                                D                                                                B2                                                                                          D                                                                D                                                                B1                                                             B1
  ST†                  ST93                            ST354                                                            ST354                                                            ST354                                                            New                                                                                         ST354                                                            ST354                                                            ST156                                                          ST156
  PFGE type            IV                              I                                                                I                                                                I                                                                V                                                                                           I                                                                I                                                                II                                                             III
  Resistance genes     *mcr-1*, *bla*~TEM-1~, *qepA*   *mcr-1*, *bla*~TEM-1~, *bla*~CTX-M-15~, *fosA3, aac(6′)-Ib*-cr   *mcr-1*, *bla*~TEM-1~, *bla*~CTX-M-15~, *fosA3, aac(6′)-Ib*-cr   *mcr-1*, *bla*~TEM-1~, *bla*~CTX-M-15~, *fosA3, aac(6′)-Ib*-cr   *mcr-1*, *bla*~TEM-1~, *bla*~SHV-12~, *bla*~CTX-M-15~, *fosA3, rmtB, qnrS, aac(6′)-Ib*-cr   *mcr-1*, *bla*~TEM-1~, *bla*~CTX-M-15~, *fosA3, aac(6′)-Ib*-cr   *mcr-1*, *bla*~TEM-1~, *bla*~CTX-M-15~, *fosA3, aac(6′)-Ib*-cr   *mcr-1*, *bla*~TEM-1~, *bla*~CTX-M-55~, *fosA3, rmtB, qepA1*   *mcr-1*, *bla*~IMP-4~, *bla*~TEM-1~, *bla*~CTX-M-55~, *fosA3, rmtB, qepA1*
  MIC, μg/mL                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  Colistin             16                              8                                                                8                                                                16                                                               16                                                                                          8                                                                8                                                                8                                                              64
  Polymyxin B          16                              16                                                               16                                                               32                                                               16                                                                                          16                                                               8                                                                8                                                              64
  Ampicillin           \>256                           \>256                                                            \>256                                                            \>256                                                            \>256                                                                                       \>256                                                            \>256                                                            \>256                                                          \>256
  AMX/CLV              16                              32                                                               32                                                               32                                                               256                                                                                         16                                                               32                                                               16                                                             16
  Cefotaxime           64                              \>256                                                            256                                                              \>256                                                            256                                                                                         \>256                                                            256                                                              256                                                            \>256
  Ceftazidime          16                              256                                                              128                                                              256                                                              64                                                                                          256                                                              128                                                              32                                                             \>256
  Cefepime             8                               256                                                              128                                                              256                                                              16                                                                                          256                                                              64                                                               64                                                             \>256
  Gentamicin           128                             \>256                                                            \>256                                                            \>256                                                            256                                                                                         \>256                                                            \>256                                                            \>256                                                          \>256
  Amikacin             4                               \>256                                                            \>256                                                            \>256                                                            \>256                                                                                       \>256                                                            \>256                                                            \>256                                                          \>256
  Ertapenem            \<0.25                          1                                                                0.5                                                              0.25                                                             \<0.25                                                                                      1                                                                0.5                                                              \<0.25                                                         \>16
  Imipenem             \<0.25                          \<0.25                                                           \<0.25                                                           \<0.25                                                           \<0.25                                                                                      \<0.25                                                           \<0.25                                                           \<0.25                                                         \>16
  Meropenem            \<0.25                          \<0.25                                                           \<0.25                                                           \<0.25                                                           \<0.25                                                                                      \<0.25                                                           \<0.25                                                           \<0.25                                                         \>16
  Fosfomycin           32                              \>512                                                            \>512                                                            \>512                                                            \>512                                                                                       \>512                                                            \>512                                                            \>512                                                          \>512
  Tigecycline          \<2                             \<2                                                              \<2                                                              \<2                                                              \<2                                                                                         \<2                                                              \<2                                                              \<2                                                            4
  Nitrofurantoin       \<16                            32                                                               32                                                               32                                                               128                                                                                         32                                                               64                                                               64                                                             32
  Ciprofloxacin        256                             128                                                              128                                                              128                                                              64                                                                                          128                                                              128                                                              256                                                            256

\*AMX/CLV, amoxicillin clavulanic acid; PFGE, pulsed-field gel electrophoresis; ST, sequence type. †By multilocus sequence typing.

We subjected all isolates to multilocus sequence typing, in accordance with the protocol described at <http://mlst.warwick.ac.uk/mlst/dbs/Ecoli>, and pulsed-field gel electrophoresis as described previously ([@R8]--[@R10]). We identified 5 *mcr-1--*positive isolates from 4 dogs (PET02--04 and PET06) and isolate EC07 as sequence type (ST) 354. Isolates PET01 and PET05, identified from cats, belonged to ST93 and a new ST strain, respectively. IsolatesEC08 and EC09, from the patients who shared the same hospital room with the pet shop worker, were ST156 ([Table](#T1){ref-type="table"}). Results of pulsed-field gel electrophoresis were consistent with multilocus sequence typing results and showed that isolates consisted of 5 types (types I to V; [Technical Appendix](#SD1){ref-type="local-data"}). Isolate EC07 was clonally related to 4 *E. coli* strains from dogs, according criteria described by Tenover et al. ([@R10]), suggesting possible transmission of *mcr-1*--harboring *E. coli* between dogs and the patient. Colistin resistance was successfully transferred to *E. coli* C600 through conjugation in all isolates, suggesting that *mcr-1* was located on transferable plasmids.

These findings suggest that *mcr-1*--producing *E. coli* can colonize companion animals and be transferred between companion animals and humans. The findings also suggest that, in addition to food animals and humans, companion animals can serve as a reservoir of colistin-resistant *E. coli*, adding another layer of complexity to the rapidly evolving epidemiology of plasmid-mediated colistin resistance in the community.

###### Technical Appendix

Pulsed-field gel electrophoresis analysis of 9 *mcr-1*--producing *Escherichia coli* isolates from companion animals and human patients, Guangzhou, China.
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